# A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease

> **NCT00250393** · PHASE2 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 64 (—)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Istradefylline (KW-6002)

## Key facts

- **NCT ID:** NCT00250393
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 64 (—)
- **Last updated:** 2012-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00250393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00250393, "A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00250393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*